Nghiên cứu hiệu quả điều trị của phương pháp tạo nhịp tái đồng bộ tim trong điều trị suy tim nặng.
Tóm tắt
Nghiên cứu hiệu quả điều trị của phương pháp tạo nhịp tái đồng bộ tim trong điều trị suy tim nặng.Tài liệu tham khảo
1. Roger VL, Weston SA, Redfield MM et al. Trends in heart failure incidence and survival in a community based population. JAMA 2004; 292:344-350.
2. Cleland JG, Daubert JC et al. Cardiac resynchronization - Heart Failure (CARE - HF) study investigators. The effect on cardiac resynchronization therapy on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539 - 9.
3. Bristow MR, Saxon LA et al. Comparsion of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac resynchronization therapy with and without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140 - 2150.
4. Abram WT, Fisher WG et al. MIRACLE study group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845 - 1853.
5. Young JB, Abraham WTet al. Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrilation in advanced chronic heart failure: MIRACLE - ICD Trial. JAMA 2003; 289: 2685 - 2694.
6. Cazeau S, Leclercq C et al. Multisite Stimualtion in Cardiomyopathies (MUSTIC) study investigators. Effects of multisite biventricular pacing in pts with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344: 873 - 880.
7. Linde C, Leclerq C et al. Long term benefits of biventricular pacing in congestive heart failure: Results from th Multisite Stimulation in cardiacmyophathy (MUSTIC) study. J Am Coll Cardiol 2002; 40: 111 - 118.
8. Auricchio A, Fantoni C, Regoli F et al. Characterization of left ventricular activation in patients with heart failure and left bundle branch block. Circulatioon 2004; 109: 1133 - 39.
9. Epstein EA, DiMarco JP et al. ACC/AHA/HRS 2008 guidelines for Device - Based therapy of Cardiac Rhythm Abnormalities. JACC 2008; 21: 1 - 62.
10. Daubert C, Gold MR, Abraham WT. Prevention of disease progression by cardiac resynchronization therapy in pts with asymptomatic of mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reversed Remodeling in Systolic Left Ventricular Dysfunction) trial. J Am Coll Cardiol 2009; Nov 10; 54 (20): 7 - 46.
11. Chung ES, Leon AR, Tavazzi L et al. Results of the Predictors of Response to CRT (PROSPECT) Trial. Circulation; 117: 2608 - 2616.
12. Beshai JF, Grimm RA, Nagueh SF et al. RethinQ Study Investigatiors. Cardiac resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med. 2007; 357: 2461 - 71.
13. Leon AR, Abraham WT, Curtis AB et al. Safety of tranvenous Cardiac Resynchronization System Implantaton in Pts with Chronic Heart Failure. JACC 2005; 46: 2348 - 56.
14. Bramlet DA, Morris KG, Coleman RE, Albert Dcobb FR. Effect of rate-dependent left bundle branch block on global and regional left ventricular function. Circulation 1983; 67: 1059-1065.
15. Prinzen FW, Augustijn CH, Arts T, Allessie MA, Reneman RS. Redistribution of myocardial fiber strain and blood flow by asynchronous activation. Am J Physiol 1990; 259: H300-H308.
16. Wyman BT, Hunter WC, Prinzen FW, McVeigh ER. Mapping propagation of mechanical activation in the paced heart with MRI tagging. Am J Physiol 1999; 276: H881 - H891.
17. Bommel RA, Borleffs CJW, Ypenburg C et al. Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implatation characteristics on long-term outcome. Eur Heart J 2010; 31 (22): 2783 - 2790.
18. Hjalmarson A, Goldstein S, Abraham WT. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001-2007.
